• Home
  • >
  • Pharmaids Pharmaceuticals Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/pharmaids-pharmaceuticals-ltd.png Logo

Pharmaids Pharmaceuticals Ltd Financial Statement

Pharmaids Pharmaceuticals Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Dec 2023Sep 2023Jun 2023
Revenue-0.88-0.260.41
Operating Expense1.321.021.61
Net Profit-1.63-0.5-1.3
Net Profit Margin185.23192.31-317.07
Earning Per Share-0.76-0.23-0.61
EBIDTA-1.62-0.49-1.29
Effective Tax RateTBATBATBA

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Pharmaids Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022
Total Revenue AnnualTBA3.94
Operating Expenses Annual9.893.8
Operating Profit Annual-9.890.15
Interest Annual00
Depreciation0.020.01
Net Profit Annual-7.560.15
Tax Annual-2.35-0

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Pharmaids Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022
Cash Flow at the Beginning0.410.2
Cash Flow from Operations-4.02-0.26
Cash Flow from Investing-4.940.47
Cash Flow from Financing21.31TBA
Cash Flow at the End12.750.41

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Pharmaids Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022
PBDIT Margin (%)TBA3.81
PBIT Margin (%)TBA3.55
PBT Margin (%)TBA3.55
Net PROFIT Margin (%)TBA3.81
Return On Networth / Equity (%)TBA1.36
Return On Networth /Employed(%)TBA1.36
Return On Assets (%)TBA1.71
Total Debt / Equity(X)TBATBA
Asset Turnover Ratio (%)TBA0.45

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Pharmaids Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022
Fixed Assets Annual0.110.03
Total Current Assets Annual17.512.67
Non Current Assets Annual7.078.44
Total Shareholders Funds Annual22.468.67
Total Assets Annual24.5911.11

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Pharmaids Pharmaceuticals Ltd Earning Calls
Dec 2023
EPS beaten by 0.00 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Pharmaids Pharmaceuticals Ltd has a market capitalization of 46.86 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Pharmaids Pharmaceuticals Ltd is debt-free with a debt-to-equity ratio of 0.00.

In FY 2023, Pharmaids Pharmaceuticals Ltd recorded a total revenue of approximately TBA Cr marking a significant milestone in the company's financial performance.

Pharmaids Pharmaceuticals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising annually..

Pharmaids Pharmaceuticals Ltd's current PE ratio is -6.20.

Pharmaids Pharmaceuticals Ltd's ROCE averaged -44.1% from the FY ending March 2023 to 2023, with a median of -44.1%. It peaked at -44.1% in March 2023, reflecting strong capital efficiency over the period..

Pharmaids Pharmaceuticals Ltd's latest EBIT is Rs. -9.91 Cr, surpassing the average EBIT of Rs. -9.91 Cr over the 5 years..